Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Garyfallia Kokkinis"'
Autor:
Marie-Christine Kyrtsonis, Dimitra Gika, Nikolaos Anagnostopoulos, Konstantinos Zervas, Panagiotis Repoussis, Anastasia Pouli, T. Economopoulos, Meletios A. Dimopoulos, Souzana Delimpasi, Evangelos Terpos, Garyfallia Kokkinis, Argyris Symeonidis, Constantinos Tsatalas, Gerasimos Pangalis, Evridiki Michali, Elina Vervessou, Athanasios Anagnostopoulos, Amalia Vassou, Eirini Katodritou
Publikováno v:
Journal of Clinical Oncology. 25:3344-3349
Purpose Alkylating agents and the anti-CD20 monoclonal antibody rituximab are among appropriate choices for the primary treatment of symptomatic patients with Waldenström macroglobulinemia (WM), and they induce at least a partial response in 30% to
Autor:
Konstantinos L. Bourantas, Panayiotis Repousis, Gerassimos A. Pangalis, Paraskevi Roussou, George Christopoulos, John Korantzis, Evridiki Michalis, Marina Stamatellou, Vassiliki Grigorakis, Ilias Mihalakeas, Antonios Papayiannis, Effimia Vrakidou, Ekaterini Stefanoudakis, Themis Kalmantis, Argyrios Symeonidis, Maria K. Angelopoulou, Garyfallia Kokkinis, Marina P. Siakantaris, Theodoros P. Vassilakopoulos
The standard CHOP regimen may cure 30-40% of patients with advanced aggressive non-Hodgkin's lymphoma (ANHL). Mitoxantrone is an anthracenedione, which is active in NHL and its toxicity profile may be more favorable than doxorubicin with respect to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a24efaaf3f94f259f42c11412419b50
http://olympias.lib.uoi.gr/jspui/handle/123456789/24241
http://olympias.lib.uoi.gr/jspui/handle/123456789/24241